PharmaLegacy Laboratories (Shanghai) Co., Ltd was founded in 10 years ago, After a period of rapid development, it has developed into a considerable size and effectiveness company of Non-Human Primates modelsx2a38631nandDMPK, NOw it is benchmark companies in 商务服务,医疗服务,医疗保健 industry.
Innovation is the cornerstones of PharmaLegacy Laboratories (Shanghai) Co., Ltds success. In the future, PharmaLegacy also hope to continue to innovate, for the majority of customers to provide Osteoporosis Modelservice. Over the years, PharmaLegacy always believe that only adhere to innovation and professional, in order to better meet customer demand for First-class service Liver Fibrosis Model. details:We have collected and validated virtually all widely used industry protocol models available, and work to meet international standards in both consistency and accuracy. Our animal models that have been established experimental procedures are validated according to proven industry benchmarks. Liver fibrosis results from chronic injury such as viral hepatitis (especially hepatitis B and C), alcohol abuse, drugs, metabolic diseases due to overload of iron or copper, congenital abnormalities or autoimmune attack of hepatocytes or bile duct epithelium. It is characterized by the encapsulation or replacement of injured tissue by a collagenous scar. Liver fibrosis is reversible, whereas cirrhosis, the later stage of fibrosis progression, featuring regenerative nodules surrounded by fibrous bands, is generally irreversible. Liver cirrhosis leads to an impaired liver function with an increased intrahepatic resistance (portal hypertension) and the development of hepatocellular carcinoma (HCC).
Adhering to the "Customer Supreme Forge Ahead" management idea, PharmaLegacy insists on providing the best quality and service of Osteoporosis Model,AutoimmuneDiseasesModel with the "customer first" principle. Wholeheartedly welcome your patronage! Official website address: www.pharmalegacy.com
bio-equip.cn
中文
